2026年美国妇科肿瘤学会（SGO）年会于4月10-13日在波多黎各的圣胡安隆重召开。2026 SGO以“科学进步、团队赋能、拥抱变革”为主题，汇聚了全球顶尖的妇科肿瘤学专家，共同探妇科肿瘤领域的突破性临床研究、新型药物研发及热点议题。

 

在2026 SGO开幕会议上，SGO主席Karen Lu博士发表演讲，对超过3000名参会者表示欢迎，并阐释大会主题。Karen Lu博士在开致辞中强调：“今年的主题反映了妇科肿瘤医生的日常工作：推进科学、赋能团队、拥抱变化（Advancing Science.Empowering Teams.Embracing Change）。SGO致力于推进科学，因为每一项创新都让我们更接近更精准、更有效的治疗。“拥抱团队”意味着我们要明白一个道理：只有团结一心，才能取得进步。“拥抱变化”要求医疗随着科学、技术和患者需求而不断演进”。

 

会议期间，本刊特邀2026 SGO年会项目主席Pamela Soliman，MD，MPH与Christine Walsh，MD，MS进行专访。两位主席深入解读了会议主题的内涵，盘点了本届大会的学术热点，并就国际学术合作机制及AI在临床中的应用前景发表了深刻见解。现将采访实录整理成文，以中英双语对照形式呈现，以飨读者。

 

 

Pamela Soliman：在确定今年SGO会议主题时，我们意识到妇科肿瘤领域从业人员聚集于此，主要是为了学习最新的治疗方案和科学研究，从而为患者提供最佳的照护。“推进科学”正体现了这一核心使命。但SGO会议的意义远不止于发布研究数据，所以我们纳入“赋能团队”和“拥抱变革”这两个主题。我们是一个规模相对较小但联系紧密的妇科肿瘤学家团体，年会是大家重逢和联系的重要契机。我们在聆听科学进展的同时，也是为了回来巩固我们这个社群的联系。

 

Pamela Soliman:When we were trying to decide what the theme of the meeting is，I think many of us from SGO come here to learn the latest treatments，new science，research，so that we can continue to offer the best care to our patients.But I think it’s more than just the science，which is why we included the other themes.We are a very small community of GYN oncologists and the annual meeting is a chance for us to all come to the same place and reconnect.We are hearing the latest science，but we’re also really coming back to connect with our community.

 

Pamela Soliman：虽然今天仅是2026 SGO会议第一天，但科学部分内容的冲击力已经极强。开幕全体会议展示了五项前瞻性的、足以改变临床实践的试验。其中两项聚焦于铂耐药卵巢癌治疗进展及近期FDA的批准方案（III期ROSELLA和KEYNOTE-B96研究分别证明在白蛋白紫杉醇基础上联合Relacorilant、在标准化疗[加或不加贝伐珠单抗]的基础上联合帕博利珠单抗，可改善了铂耐药卵巢癌患者的生存结局），另两项则关注罕见肿瘤（随机对照试验RAMP 201和NRG-GY019探索了治疗低级别浆液性卵巢癌的更优方案）。第五项试验则展示了子宫内膜癌的新数据（II期GOG-3039研究显示阿贝西利联合来曲唑在晚期/复发性子宫内膜样子宫内膜癌中展现持久活性）。仅仅在2026 SGO第一天的学术日程中，我们就真正开始看到既往研究所揭示的内容，以及未来如何改善妇瘤患者的护理。

 

Pamela Soliman:We just finished the main opening plenary session.We had the opportunity for people to present five prospective trials that are really practice-changing.Two trials were focusing on platinum-resistant ovarian cancer and the new FDA approvals.Two on rare tumors—again，prospective randomized trials really helping us understand how to tackle rare tumors，like low-grade ovarian serous cancer.The fifth trial looked at endometrial cancer.I think just on day one，we’re really kind of seeing what the research is showing us and how we can improve patient care in the future.

 

Christine Walsh：在全体会议1之后，其他会场将继续展示妇瘤领域的新型药物及新型联合治疗方案，讨论抗体药物偶联物（ADC）的进展。一场专题论坛（Focused Forum）聚焦于GLP-1拮抗剂，还有一场专题论坛关注人工智能。此外，我们还邀请了演讲者来探讨医疗中的幽默感，以及体现患者群体韧性的榜样力量。2026 SGO的议题范围非常广泛。

 

Christine Walsh:Some of our other sessions that will be coming up in the meeting will really feature some novel agents，novel treatment combinations.We’ll be hearing a lot about antibody-drug conjugates.We’re going to have a session on GLP-1 antagonists.We’re going to have a session on artificial intelligence.We have some speakers who are going to address humor in healthcare and another speaker who really embodies the resilience of the patient population we take care of.There are very broad-ranging topics in our meeting.

 

Pamela Soliman：SGO是妇科肿瘤医生的共同体，也就是照护妇科癌症女性患者的医疗提供者群体，不局限在美国。SGO会议的许多最新临床试验和合作成果都涉及世界各地的合作伙伴，有大量在世界各地进行的前沿研究。我们希望自己拥有广泛的国际影响力。我们深知国际旅行并非对所有同仁都方便易行，因此我们对虚拟会议平台做了重大改进。SGO会议的内容可以在SGO网站上按需点播，确保无法亲临现场的人也能获取最新研究并参与学术交流。

 

Pamela Soliman:SGO really is kind of the community of gynecologic oncologists，the providers that are taking care of women with GYN cancers，not only one origination centered in the United States.We have a lot of collaborators on trials，a lot of late-breaking research that’s happening all over the world.We’re hoping that we have a big international presence.We recognize that travel is not always easy or possible for all our colleagues，which is why really wanted to improve the virtual platform.A lot of the science and things that are presented at SGO website to be available on-demand for people who couldn’t attend in person as well.

 

Christine Walsh：当然，我们非常希望如此。在组建科学委员会时，我们非常注重邀请和吸纳国际同仁。我们希望未来的SGO会议能继续保持这一做法。与韩国妇科肿瘤学会（KSGO）和日本妇科肿瘤学会（JSGO）的联合专场在过去几年一直是会议的组成部分。作为一个组织，SGO非常愿意与其他国家的妇科肿瘤学会举办类似的专属学术会议，只要双方都有合作的意愿和需求。我们非常期待在未来拓展此类区域性的国际合作。

 

Christine Walsh:We certainly hope so.When we were putting together the program committee，we were very mindful about inviting and involving our international colleagues.We’re hoping that with future SGO meetings，this will continue to be the case.The joint session with KSGO and JSGO has been a session for the past few years at this meeting.As an organization，SGO would be open to gynecologic oncology societies from other countries to hold their own sessions if there is a will.

 

Pamela Soliman：这个问题问得很好。我们认为AI在该领域的潜力是无限的。在临床方面，我们设想AI能够简化日常工作流程，减轻文书工作和行政事务负担，让我们这些医护人员能将更多时间真正投入到患者照护中。在影像解读、以及在医护团队和不同机构间安全高效地共享信息等方面，AI已经产生了巨大影响。在研究方面，AI也有无限的应用前景，包括利用诊断相似的疾病患者的大数据集，更全面地理解患者的治疗结局。

 

Pamela Soliman:That’s a great question.And I think the sky is the limit.In my mind，when I think about how AI can impact us as physicians or as providers，I think that it can impact our day-to-day—like，how do we take care of patients?How do we be more efficient so that we can actually spend more time actually taking care of patients instead of kind of the paperwork and things like that.I think there’s a huge clinical impact with sort of how images are getting read，how information is shared—both kind of within a team but then also between different providers at different institutions.And then I think there’s also an unlimited research impact.So how can we take large datasets of patients with kind of to really understand outcomes in a more comprehensive way?

 

Christine Walsh：2026 SGO第一天已举办了一场关于利用AI提升运营效率的大师课（大师班#HashtagThis 3.0分会场探讨了负责任的AI应用，以及社交媒体如何推动教育、研究和患者参与），会议第二天还将有一场专门深入探讨AI的专题论坛（聚焦利用AI减少工作负担，提升绩效）。

 

Christine Walsh:We had a session earlier today in one of our master classes where there were some speakers addressing how AI can be used to improve our operational efficiencies.And then we will have another session later in the meeting，a workshop that is fully dedicated to that topic.